Transition to Oral Antihypertensives After Cardene (Nicardipine) Infusion
After discontinuing a Cardene (nicardipine) drip in a hemodynamically stable patient, initiate oral antihypertensive therapy immediately upon stopping the infusion if using agents other than oral nicardipine, or administer the first dose of oral nicardipine 1 hour before discontinuing the IV infusion. 1
Understanding the Pharmacokinetics
The critical timing issue stems from nicardipine's offset kinetics:
- Blood pressure begins rising within 30 minutes after stopping the infusion, with approximately 50% offset of the antihypertensive effect occurring in this timeframe 1
- This creates a narrow window for establishing oral coverage before losing BP control
Specific Transition Strategies
If Transitioning to Oral Nicardipine
- Administer the first oral dose 1 hour prior to discontinuing the IV infusion 1
- This allows time for oral absorption and therapeutic levels to develop before IV effects wane
- Use equivalent dosing based on the IV infusion rate (see conversion table below)
If Transitioning to Other Oral Antihypertensives
- Initiate therapy upon discontinuation of the Cardene infusion 1
- Do not delay oral medication administration
- Common oral agents include:
- Calcium channel blockers (amlodipine, nifedipine extended-release)
- ACE inhibitors or ARBs for long-term management
- Beta-blockers (labetalol, metoprolol) if no contraindications exist
- Combination therapy may be necessary depending on baseline hypertension severity
IV-to-Oral Nicardipine Conversion
If continuing nicardipine therapy orally, use these equivalents 1:
| IV Infusion Rate | Oral Nicardipine Dose |
|---|---|
| 0.5 mg/hr | 20 mg every 8 hours |
| 1.2 mg/hr | 30 mg every 8 hours |
| 2.2 mg/hr | 40 mg every 8 hours |
Blood Pressure Targets Post-Transition
The approach differs based on whether the patient had a hypertensive emergency:
For Patients Who Had Hypertensive Emergency (Without Compelling Conditions)
- First hour: Reduce SBP by no more than 25% from initial presentation 2, 3
- Next 2-6 hours: Target <160/100 mm Hg if stable 2, 3
- Next 24-48 hours: Cautiously reduce to 130-140 mm Hg 3
For Patients With Severe Hypertension (No Acute Target Organ Damage)
- Avoid aggressive acute lowering 3
- Reinstitute or intensify oral medications with outpatient follow-up
- Target standard BP goals (<130/80 mm Hg) over days to weeks, not hours
Critical Monitoring Points
Monitor BP every 15-30 minutes for the first 2 hours after transition to detect:
- Rebound hypertension from inadequate oral coverage
- Excessive hypotension from overlapping effects
- Adjust oral dosing based on response
Common Pitfalls to Avoid
- Delaying oral medication initiation: The 30-minute offset window is unforgiving—start oral therapy on time
- Assuming hemodynamic stability means no monitoring needed: Even stable patients require close BP surveillance during transition
- Using intermittent IV boluses for BP spikes: In hospitalized patients with severe hypertension but no acute target organ damage, avoid additional IV or oral "as needed" antihypertensives for acute reduction 3—this approach increases adverse events without improving outcomes
- Inadequate dose conversion: Underdosing oral medications leads to rebound hypertension; use equivalent dosing tables
Special Populations Requiring Slower Titration
Exercise particular caution in patients with 1:
- Heart failure (risk of hypotension)
- Hepatic impairment (prolonged drug effects)
- Renal dysfunction (altered clearance)
These patients may need lower initial oral doses and more gradual BP reduction targets.
Note on Dopamine Confusion
The question mentions "dopamine (Cardene)," but Cardene is nicardipine, not dopamine. Dopamine is a separate vasopressor used for hypotension 4, 5, not hypertension. If the patient was actually on dopamine infusion for hypotension, the transition strategy would be entirely different—focusing on maintaining adequate perfusion rather than BP reduction. Clarify which medication was actually used before proceeding.